Sanare's approach may be a new way in medicine, where the healing processes are discovered and amplified, and the products transformed into actual cures. Instead of amplifying the defect or the disease in scientific detail, Sanare A.S. amplifies the solution given by the body and identifies it. Sanare A.S. wishes furthermore to give revenue to its investors, and may underline that the revenues in pharmaceutical companies reach beyond the costs of developing the products, which can be up to 2000 million USD (Bureau of Economics, Federal TradeCommission, Washington, DC, Adams and Bratner, 2006). With a high market value of a bodily breast cancer treatment, Sanare A.S. will provide a significant revenue at a very low risk for the investor. Also, given the bodily essence of the products of Sanare A.S, the few or no side-effects, as partly proven, may ease substantially the time taken to pass through legislations.